---
title: "Clearbridge R (9RQR.SG)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/9RQR.SG.md"
symbol: "9RQR.SG"
name: "Clearbridge R"
datetime: "2026-05-21T14:40:31.995Z"
locales:
  - [en](https://longbridge.com/en/quote/9RQR.SG.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/9RQR.SG.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/9RQR.SG.md)
---

# Clearbridge R (9RQR.SG)

## Company Overview

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products.

| Item | Detail |
|------|--------|
| Exchange | SG Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/9RQR.SG/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/9RQR.SG/norm.md)
- [Related News](https://longbridge.com/en/quote/9RQR.SG/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**